SAY YES TO WHAT'S NEXT!
Your partner for pharmaceutical development and manufacturing with fast, flexible and personalised solutions for worldwide markets.
We are one of the leading European contract manufacturers in the pharmaceutical, biotech and healthcare industries. For us, the most important step is always the next. Because speed drives us, fills our working world with dynamism and allows us to grow. Our best recipe for joint success: space for passion. Because we are sure: Where excellent service inspires, passion is the best medicine.
Welcome to NextPharma
In our world, the next step is always the one that matters most. Because passion deserves to be given free rein. That’s why our winning formula for shared success is ‘room for passion.’ For more than 2,000 employees at our sites in Berlin, Bielefeld, Göttingen and Waltrop (Germany), Limay and Ploermel (France), Tampere (Finland) and Edinburgh (UK).
NextPharma develops and produces a broad range of pharmaceutical dosage forms:
• Solids (tablets, capsules, powders, controlled-release pellets)
• Liquids (suspensions, syrups, solutions)
• Semi-solids (creams, gels, ointments, suppositories)
Special containment areas are available for:
• Hormones (solid and semi-solid)
• Narcotics (controlled substances)
• Beta lactam antibiotics (solids, liquids, dry syrups)
• and clinical trials services.
Career opportunities
Passion meets prospects
Joining NextPharma means taking the next step. A strong step forward. Because you will be adding prospects to your passion. With vision. Whether you are a school-leaver, an entry-level candidate, a specialist or an executive: the pharmaceutical, biotech and healthcare industries are full of challenges and future potential. And it’s a future that we at NextPharma want to shape. Together with you.
#SPEED #PASSION #SERVICE
Your partner for pharmaceutical development and manufacturing with fast, flexible and personalised solutions for worldwide markets.
We are one of the leading European contract manufacturers in the pharmaceutical, biotech and healthcare industries. For us, the most important step is always the next. Because speed drives us, fills our working world with dynamism and allows us to grow. Our best recipe for joint success: space for passion. Because we are sure: Where excellent service inspires, passion is the best medicine.
Welcome to NextPharma
In our world, the next step is always the one that matters most. Because passion deserves to be given free rein. That’s why our winning formula for shared success is ‘room for passion.’ For more than 2,000 employees at our sites in Berlin, Bielefeld, Göttingen and Waltrop (Germany), Limay and Ploermel (France), Tampere (Finland) and Edinburgh (UK).
NextPharma develops and produces a broad range of pharmaceutical dosage forms:
• Solids (tablets, capsules, powders, controlled-release pellets)
• Liquids (suspensions, syrups, solutions)
• Semi-solids (creams, gels, ointments, suppositories)
Special containment areas are available for:
• Hormones (solid and semi-solid)
• Narcotics (controlled substances)
• Beta lactam antibiotics (solids, liquids, dry syrups)
• and clinical trials services.
Career opportunities
Passion meets prospects
Joining NextPharma means taking the next step. A strong step forward. Because you will be adding prospects to your passion. With vision. Whether you are a school-leaver, an entry-level candidate, a specialist or an executive: the pharmaceutical, biotech and healthcare industries are full of challenges and future potential. And it’s a future that we at NextPharma want to shape. Together with you.
#SPEED #PASSION #SERVICE
Location: United Kingdom, England, Westminster
Employees: 1001-5000
Founded date: 1946
Investors 4
| Date | Name | Website |
| - | CapVest As... | capvest.co... |
| - | CapVest | capvest.co... |
| - | Sun Capita... | suncappart... |
| - | Sun Europe... | suneuropea... |
Mentions in press and media 6
| Date | Title | Description |
| 01.09.2025 | CapVest из Лондона покупает 70% фармпроизводителя Stada у инвестфондов Bain и Cinven за €10 млрд | Лондонская инвестиционная компания приобретает контрольный пакет у нынешних владельцев Stada — фондов частных инвестиций Bain Capital и Cinven, которые сохранят миноритарную долю после завершения сделки, говорится в заявлении в понедельник.... |
| 11.07.2025 | René Eve appointed as Director of Operations of Bioretec Ltd. | René Eve appointed as Director of Operations of Bioretec Ltd. Fri, Jul 11, 2025 07:00 CET Report this content Bioretec Ltd Press release 11. July 2025 at 8.00 am Bioretec has appointed Bachelor of Technology René Eve as the company’s Direct... |
| 31.08.2017 | An Affiliate of Sun European Partners, LLP, completes the sale of NextPharma | Sun European Partners, LLP (“Sun European Partners” or “Sun”) today announces that one of its affiliates has completed the sale of its investment in NextPharma (or “the company”), a leading pharmaceutical contract development and manufactur... |
| 31.08.2017 | An affiliate of Sun European Partners, LLP, completes the sale of NextPharma | Sun European Partners, LLP (“Sun European Partners” or “Sun”) today announces that one of its affiliates has completed the sale of its investment in NextPharma (or “the company”), a leading pharmaceutical contract development and manufactur... |
| 28.06.2017 | An affiliate of Sun European Partners, LLP, announces that it has agreed to sell NextPharma | Sun European Partners, LLP (“Sun European Partners” or “Sun”) today announces that one of its affiliates has signed a definitive agreement to sell NextPharma (or “the company”), a leading pharmaceutical contract development and manufacturin... |
| 28.06.2017 | An affiliate of Sun European Partners, LLP, announces that it has agreed to sell NextPharma | Sun European Partners, LLP (“Sun European Partners” or “Sun”) today announces that one of its affiliates has signed a definitive agreement to sell NextPharma (or “the company”), a leading pharmaceutical contract development and manufacturin... |